We are dedicated to pioneering data-driven research in human immunometabolism, employing state-of-the-art multi-omics technologies and innovative computational methods. Our primary goal is to devise non-invasive approaches for early disease diagnostics and unravel the intricate cellular and molecular mechanisms underlying human disease progression.